The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on September 8, 2026

Sep. 8, 2026

Newcore Gold Announces Appointment of Mr. Sulemanu Koney to its Board of Directors

Indeterminate GlobeNewswire

Sep. 8, 2026

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event

Indeterminate GlobeNewswire

Sep. 8, 2026

Invivyd to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Indeterminate GlobeNewswire

Sep. 8, 2026

G3 Goldfields Provides Update on Listing

Indeterminate GlobeNewswire

Sep. 8, 2026

BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer

Indeterminate GlobeNewswire

Sep. 8, 2026

BrainChild Bio Closes $116 Million Series A Financing

Indeterminate GlobeNewswire

Sep. 8, 2026

Lahontan Strengthens Technical, Engineering, and Business Development Team

Indeterminate GlobeNewswire

Sep. 8, 2026

OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks

Indeterminate GlobeNewswire

Sep. 8, 2026

Bullish releases August 2026 monthly metrics

Indeterminate GlobeNewswire

Sep. 8, 2026

DPM Metals Extends Mineralization at Dumitru Potok with High-Grade Intercepts

Indeterminate GlobeNewswire

Sep. 8, 2026

Nova Minerals’ Marches towards Antimony Production with Arrival of Processing & Refining Equipment in Alaska

Indeterminate GlobeNewswire

Sep. 8, 2026

Pulmovant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study

Indeterminate GlobeNewswire

Sep. 8, 2026

Cytospire Therapeutics Appoints Highly Experienced Immuno-Oncology Leader, Sumeet Ambarkhane, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Discovery Announces Management Changes

Indeterminate GlobeNewswire